S Singh

Summary

Publications

  1. ncbi Generic versus non-generic formulation of extended-release clarithromycin in patients with community-acquired respiratory tract infections: a prospective, randomized, comparative, investigator-blind, multicentre study
    J R Snyman
    Department of Pharmacology, School of Medicine, University of Pretoria, Pretoria, South Africa
    Clin Drug Investig 29:265-74. 2009

Collaborators

  • J R Snyman
  • H S Schoeman
  • W Rabie
  • M Hira
  • M Henning
  • Y Mithal
  • M P Grobusch
  • K Parshotam
  • Z Ramdas

Detail Information

Publications1

  1. ncbi Generic versus non-generic formulation of extended-release clarithromycin in patients with community-acquired respiratory tract infections: a prospective, randomized, comparative, investigator-blind, multicentre study
    J R Snyman
    Department of Pharmacology, School of Medicine, University of Pretoria, Pretoria, South Africa
    Clin Drug Investig 29:265-74. 2009
    ..In order to address this concern, two modified-release formulations of clarithromycin (i.e. the originator Klacid XL and the generic Klarithran MR) were compared in patients with acute community-acquired respiratory tract infections...